Acadia Pharma (ACAD) Misses Q1 View By 4c
More News related to ACAD
- ACADIA Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 9, 2009
- ACADIA Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26, 2009
- ACADIA Pharma (ACAD) to Cut Workforce by 50%
- Unusual 11 Mid-Day Movers 10/06: FONR, ICTG, ACAD, AVCT Higher; MNKD, VRNMD, ARP, PPD Lower
- ACADIA Pharmaceuticals (ACAD) Shares Rise Sharply on Pimavanserin Update
More News related to Earnings
- Highlights From DISH's Q3 Conference Call - Q&A Session
- Gulf Resources (GFRE) Posts Q3 EPS of $0.27, Up Y/Y; Revs Higher
- Hemispherx Biopharma (HEB) Reports a Q3 Loss; Comments on FDA Responses
- Comstock Homebuilding Co. (CHCI) Posts Q3 EPS of $0.13; Even Y/Y
- Willis Lease Finance (WLFC) Posts Q3 EPS of $0.94, Better Y/Y
Acadia Pharma (Nasdaq: ACAD) reports Q1 EPS of ($0.40), 4 cents below the analyst estimate of ($0.36). Revenue for the quarter was $374k, versus the consensus of $540K.
Related Categories
EarningsStocks Mentioned
+0.04Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
